alanine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 5 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the very specific nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations." | 2.72 | COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE). ( Baruchel, A; Bertrand, Y; Boissel, N; Brethon, B; Ducassou, S; Gandemer, V; Halfon-Domenech, C; Leblanc, T; Leverger, G; Michel, G; Petit, A; Ray-Lunven, AF; Rohrlich, PS; Rouger-Gaudichon, J; Schneider, P; Sirvent, N; Strullu, M, 2021) |
| "Acute and chronic myeloid leukemia are initiated and sustained by a small, self-renewing population of leukemic stem cells, which produce progeny of a heterogeneous population of progenitor cells." | 1.40 | Stromal cell derived factor-1 (CXCL12) chemokine gene variant in myeloid leukemias. ( Bahaa, NM; El-Ghany, HM; El-Saadany, ZA; Hussien, SM; Ibrahim, NY, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rouger-Gaudichon, J | 1 |
| Bertrand, Y | 1 |
| Boissel, N | 1 |
| Brethon, B | 1 |
| Ducassou, S | 1 |
| Gandemer, V | 1 |
| Halfon-Domenech, C | 1 |
| Leblanc, T | 1 |
| Leverger, G | 1 |
| Michel, G | 1 |
| Petit, A | 1 |
| Ray-Lunven, AF | 1 |
| Rohrlich, PS | 1 |
| Schneider, P | 1 |
| Sirvent, N | 1 |
| Strullu, M | 1 |
| Baruchel, A | 1 |
| El-Ghany, HM | 1 |
| El-Saadany, ZA | 1 |
| Bahaa, NM | 1 |
| Ibrahim, NY | 1 |
| Hussien, SM | 1 |
| Barrientos, JC | 1 |
| Dubey, KD | 1 |
| Ojha, RP | 1 |
| Smith, KM | 1 |
| Yacobi, R | 1 |
| Van Etten, RA | 1 |
2 reviews available for alanine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).
Topics: Adenosine Monophosphate; Adolescent; Adrenal Cortex Hormones; Alanine; Antiviral Agents; Cancer Care | 2021 |
Sequencing of chronic lymphocytic leukemia therapies.
Topics: Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothe | 2016 |
3 other studies available for alanine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Stromal cell derived factor-1 (CXCL12) chemokine gene variant in myeloid leukemias.
Topics: 3' Untranslated Regions; Adolescent; Adult; Aged; Alanine; Case-Control Studies; Chemokine CXCL12; F | 2014 |
Conformational flexibility, binding energy, role of salt bridge and alanine-mutagenesis for c-Abl kinase complex.
Topics: Alanine; Benzamides; Binding Sites; Glutamic Acid; Humans; Hydrogen Bonding; Imatinib Mesylate; Leuk | 2012 |
Autoinhibition of Bcr-Abl through its SH3 domain.
Topics: 3T3 Cells; Alanine; Amino Acid Sequence; Animals; Binding Sites; Catalytic Domain; Cell Transformati | 2003 |